Role Definition
| Field | Value |
|---|---|
| Job Title | Medical Dosimetrist |
| Seniority Level | Mid-Level (3-7 years) |
| Primary Function | Designs radiation therapy treatment plans for cancer patients. Using treatment planning systems (RayStation, Eclipse), creates optimal dose distributions that maximise tumour coverage while minimising radiation to healthy organs. Contours organs at risk (OARs) and target volumes on CT/MRI images, runs plan optimisation algorithms, evaluates dosimetric quality (DVH analysis), presents plans to radiation oncologists for approval, performs quality assurance measurements, and manages adaptive re-planning when patient anatomy changes during treatment. Works entirely at a computer workstation in a radiation oncology department. |
| What This Role Is NOT | NOT a Radiation Therapist (who physically positions patients and operates the linac — that role scores 54.5 Green Transforming). NOT a Medical Physicist (who oversees machine commissioning, calibration, and radiation safety programme management). NOT a Radiation Oncologist (physician who prescribes treatment, approves plans, and bears ultimate clinical accountability). |
| Typical Experience | 3-7 years. Bachelor's or master's degree in medical dosimetry or related field. CMD (Certified Medical Dosimetrist) credential from MDCB required. ~4,800 employed nationally (BLS 2024). Median salary $138,110. |
Seniority note: Entry-level dosimetrists performing the same planning tasks under closer supervision would score similarly or slightly lower. Senior/chief dosimetrists with supervisory, protocol development, and AI integration oversight responsibilities would score higher, potentially reaching low Green.
Protective Principles + AI Growth Correlation
| Principle | Score (0-3) | Rationale |
|---|---|---|
| Embodied Physicality | 0 | Fully desk-based. All work occurs at a computer workstation using treatment planning software. No physical patient contact. No manual tasks that require physical presence. |
| Deep Interpersonal Connection | 1 | Some interaction with radiation oncologists when presenting plans, and occasional patient contact for measurements. But the core value is computational and technical, not relational. |
| Goal-Setting & Moral Judgment | 1 | Makes clinical judgment calls about plan quality, dose trade-offs, and when to escalate concerns. But operates within physician-prescribed parameters — the radiation oncologist sets the treatment goals and approves the final plan. |
| Protective Total | 2/9 | |
| AI Growth Correlation | 0 | Demand driven by cancer incidence and aging population, not AI adoption. AI neither creates nor destroys demand for dosimetrists — it changes how they work. Neutral. |
Quick screen result: Low protective score (2/9) with neutral correlation — likely Yellow Zone. The absence of physicality is the critical differentiator from Radiation Therapist (54.5, Green Transforming).
Task Decomposition (Agentic AI Scoring)
| Task | Time % | Score (1-5) | Weighted | Aug/Disp | Rationale |
|---|---|---|---|---|---|
| Treatment plan design & optimisation | 30% | 3 | 0.90 | AUGMENTATION | Plan AI (Sun Nuclear/Oncospace), RapidPlan (Eclipse), and RayStation ML-based planning generate full treatment plans in minutes. The dosimetrist reviews, refines, and optimises AI-generated plans. AI creates initial plan; human adds clinical judgment and patient context. |
| OAR & target contouring | 20% | 3 | 0.60 | AUGMENTATION | Auto-contouring (Limbus AI, MVision, RayStation DL segmentation) reduces contouring from half a day to under an hour. Dosimetrist reviews and edits AI-generated contours. Core drawing task is AI-executed; validation remains human. |
| Plan quality review & dosimetric evaluation | 15% | 2 | 0.30 | AUGMENTATION | Evaluating DVH metrics, assessing plan acceptability, identifying dosimetric trade-offs. This is where the dosimetrist's clinical expertise is most valuable. AI suggests optimisations; the dosimetrist determines if the plan meets clinical goals for the specific patient. |
| Physician consultation & plan presentation | 10% | 2 | 0.20 | AUGMENTATION | Presenting plans to radiation oncologists, discussing dose trade-offs, recommending plan modifications. Requires clinical communication skills and professional judgment. AI provides data; the dosimetrist interprets and communicates. |
| Quality assurance & plan verification | 10% | 3 | 0.30 | AUGMENTATION | AI algorithms predict QA passing rates and identify potential errors. Patient-specific QA measurements and independent dose calculations increasingly automated. Dosimetrist oversees and validates QA workflow. |
| Adaptive re-planning & plan modification | 10% | 3 | 0.30 | AUGMENTATION | AI-driven adaptive radiotherapy systems (Ethos, RayStation adaptive) auto-generate adapted plans when patient anatomy changes. Dosimetrist evaluates adapted plans for clinical acceptability. Rapid re-planning shifts from manual to AI-generated with human validation. |
| Documentation & record-keeping | 5% | 4 | 0.20 | DISPLACEMENT | Treatment planning records, dose reports, regulatory documentation. Record-and-verify systems (ARIA, MOSAIQ) increasingly automate. Human reviews and signs off. |
| Total | 100% | 2.80 |
Task Resistance Score: 6.00 - 2.80 = 3.20/5.0
Displacement/Augmentation split: 5% displacement, 95% augmentation, 0% not involved.
Reinstatement check (Acemoglu): Yes — AI creates new tasks: evaluating AI-generated plans, validating auto-contours, managing adaptive re-planning workflows, curating training data for AI models, and integrating AI tools into clinical protocols. The role shifts from plan creator to plan evaluator and AI workflow manager. However, these reinstatement tasks require fewer person-hours than the original manual tasks — efficiency gains compress headcount rather than expand it.
Evidence Score
| Dimension | Score (-2 to 2) | Evidence |
|---|---|---|
| Job Posting Trends | 0 | BLS projects 3% growth 2024-2034, about average. Only ~200 openings per year in a workforce of 4,800. Stable but thin labour market. No surge or decline. |
| Company Actions | 0 | No hospitals or cancer centres cutting dosimetrist positions citing AI. No expansion signals either. AI auto-planning adopted widely but affects workflow efficiency, not headcount — yet. AAMD and MDCB actively developing AI-focused continuing education. |
| Wage Trends | 1 | Median $138,110 (BLS May 2024) — strong compensation reflecting specialised skills and CMD certification. Well above the $49,500 national median. Wages stable to modestly growing, outpacing inflation. |
| AI Tool Maturity | -1 | Plan AI, RapidPlan, auto-contouring (Limbus AI, MVision, RayStation DL), and adaptive planning systems are in production and performing 50-80% of core planning tasks with human oversight. These tools directly target the dosimetrist's primary workflow. AI tool maturity is higher here than for most healthcare roles. |
| Expert Consensus | 1 | AAMD, MDCB, and academic literature unanimously frame AI as transformation not displacement. Brian Napolitano (Mass General): AI will "allow dosimetrists to work smarter and automate routine tasks." SROA: "AI is a complement to, not a replacement for, dosimetrists." But consensus acknowledges significant role transformation is underway. |
| Total | 1 |
Barrier Assessment
Reframed question: What prevents AI execution even when programmatically possible?
| Barrier | Score (0-2) | Rationale |
|---|---|---|
| Regulatory/Licensing | 2 | CMD (Certified Medical Dosimetrist) credential from MDCB required. Accredited programme prerequisite (bachelor's or master's). State regulations mandate qualified personnel for treatment planning. FDA classifies treatment planning systems as medical devices. No regulatory pathway for AI to independently generate and approve treatment plans. |
| Physical Presence | 0 | Fully desk-based role. All work occurs at a computer workstation. No physical patient contact requirement. This is the key vulnerability — unlike the radiation therapist at the linac, there is no physical barrier to remote or AI execution of the computational work. |
| Union/Collective Bargaining | 0 | Minimal union representation. No collective bargaining protections specific to dosimetrists. |
| Liability/Accountability | 2 | Treatment planning errors can cause catastrophic patient harm — radiation overdose, underdose to tumours, damage to critical organs. Someone must bear professional liability for the plan. The radiation oncologist approves, but the dosimetrist who designed the plan shares professional accountability. AI cannot be held liable. |
| Cultural/Ethical | 1 | Moderate expectation that cancer treatment plans involve human expertise. Patients and oncologists want a human professional designing the radiation plan, not a fully autonomous AI. The trust requirement is real but less visceral than bedside care — patients rarely meet the dosimetrist. |
| Total | 5/10 |
AI Growth Correlation Check
Confirmed 0 (Neutral). AI adoption in radiation oncology automates the dosimetrist's core planning tasks but does not create new demand for dosimetrists. Demand is driven by cancer incidence, aging demographics, and expanding radiotherapy indications. AI makes each dosimetrist more productive — which is positive for the individual but negative for total headcount demand. This is a productivity trap: AI saves time per plan, so fewer dosimetrists can serve the same patient volume.
JobZone Composite Score (AIJRI)
| Input | Value |
|---|---|
| Task Resistance Score | 3.20/5.0 |
| Evidence Modifier | 1.0 + (1 × 0.04) = 1.04 |
| Barrier Modifier | 1.0 + (5 × 0.02) = 1.10 |
| Growth Modifier | 1.0 + (0 × 0.05) = 1.00 |
Raw: 3.20 × 1.04 × 1.10 × 1.00 = 3.6608
JobZone Score: (3.6608 - 0.54) / 7.93 × 100 = 39.4/100
Zone: YELLOW (Green ≥48, Yellow 25-47, Red <25)
Sub-Label Determination
| Metric | Value |
|---|---|
| % of task time scoring 3+ | 75% |
| AI Growth Correlation | 0 |
| Sub-label | Yellow (Urgent) — AIJRI 25-47 AND ≥40% task time scores 3+ |
Assessor override: None — formula score accepted. The 39.4 score is 8.6 points below the Green Zone boundary. The dosimetrist's desk-based, computational workflow makes it the most AI-exposed role in the radiation oncology team. Compare to Radiation Therapist (54.5) who benefits from physicality at the linac, and Radiologist (52.7) who benefits from higher licensing/liability barriers. The dosimetrist's position between these roles and the pharmacist (42.0) — another highly skilled, desk-based, AI-exposed healthcare professional — is calibrationally sound.
Assessor Commentary
Score vs Reality Check
The Yellow (Urgent) classification honestly reflects the dosimetrist's position: highly skilled, well-compensated, strongly licensed — but sitting at a workstation doing exactly the computational work that AI targets in radiation oncology. The 39.4 score is not borderline (8.6 points from Green). The role is barrier-dependent: if CMD certification and physician oversight mandates weakened, the score would drop further. The barriers (5/10) are doing meaningful work — without them, the pure task resistance (3.20) and modest evidence (+1) would place this role near the Yellow/Red boundary. No override is warranted because the market data (stable employment, strong wages, no layoffs) confirms Yellow rather than Red.
What the Numbers Don't Capture
- Productivity trap. AI auto-planning and auto-contouring make each dosimetrist dramatically more productive. A dosimetrist who once handled 3-4 plans per day may handle 6-8 with AI assistance. This is good for the individual but could suppress headcount growth. The BLS 3% growth projection may already account for this compression, but it bears watching.
- Small workforce vulnerability. With only 4,800 workers and 200 annual openings, the dosimetrist labour market is exceptionally thin. Even modest AI-driven efficiency gains could visibly reduce the number of open positions. A single large health system consolidating dosimetry workflow with AI tools could meaningfully shift national employment trends.
- Role boundary erosion. As AI handles more of the plan generation, the remaining human work (plan review, QA oversight, physician consultation) overlaps with what medical physicists already do. Some departments may consolidate dosimetrist and physicist roles, reducing distinct dosimetrist headcount.
- Adaptive radiotherapy expansion. Online adaptive systems (Varian Ethos, Elekta Unity) create real-time re-planning workflows that could either increase dosimetrist workload (more plans per patient) or bypass them entirely if AI adaptation becomes autonomous. This is an unresolved variable.
Who Should Worry (and Who Shouldn't)
If you are a medical dosimetrist whose primary daily work involves manual contouring, trial-and-error plan optimisation, and routine plan generation for standard cases — your workflow is being compressed right now. AI auto-contouring reduces half-day contouring tasks to under an hour. Auto-planning generates clinically acceptable plans in minutes. The manual artisanship of dosimetry is eroding.
If you are the dosimetrist who evaluates plan quality, identifies dosimetric trade-offs that AI misses, manages complex cases (re-irradiation, paediatric, multi-site), leads AI integration projects, and serves as the clinical bridge between the treatment planning system and the radiation oncologist — you are in a stronger position than the label suggests. The role is shifting from plan creator to plan evaluator and AI workflow manager.
The single biggest factor: whether your value comes from generating plans or from evaluating them. Generators are being replaced by algorithms. Evaluators are being elevated.
What This Means
The role in 2028: Medical dosimetrists will spend less time drawing contours and running optimisation iterations, and more time validating AI-generated plans, managing adaptive re-planning workflows, and providing clinical judgment on complex cases. The profession will require AI literacy as a core competency — MDCB is already integrating AI into continuing education requirements. Departments may need fewer dosimetrists per patient volume, but the remaining dosimetrists will work at a higher clinical level.
Survival strategy:
- Become the plan evaluator, not just the plan creator — develop expertise in critically assessing AI-generated plans, identifying dosimetric trade-offs AI misses, and managing complex cases that require human judgment
- Master AI treatment planning tools — Plan AI, RapidPlan, auto-contouring platforms (Limbus AI, MVision), and adaptive planning systems are the tools you must own, not compete with
- Pursue specialisation in complex planning — re-irradiation, paediatric dosimetry, proton therapy, brachytherapy, and multi-modality treatment planning remain areas where AI tools are weakest and human expertise is most valued
Where to look next. If you are considering a career shift, these Green Zone roles share transferable skills with medical dosimetry:
- Radiation Therapist (AIJRI 54.5) — your treatment planning knowledge transfers directly, and the hands-on linac-side work adds physical protection AI cannot replace
- Radiologic Technologist (AIJRI 56.5) — imaging technology expertise overlaps, with stronger physical presence protection
- Medical Equipment Repairer (AIJRI 59.2) — technical troubleshooting skills transfer to maintaining the treatment planning and delivery hardware you already understand
Browse all scored roles at jobzonerisk.com to find the right fit for your skills and interests.
Timeline: 2-5 years. AI auto-planning and auto-contouring are in production now and improving rapidly. The workforce compression is already underway — 200 annual openings for 4,800 workers is a thin replacement pipeline. The role does not disappear, but it transforms fundamentally, and fewer dosimetrists may be needed per department.
